Colchicine and Inflammation in Hemodialysis Patients
Condition:   End Stage Renal Disease on Dialysis Interventions:   Drug: Colchicine 0.5 MG;   Drug: Placebo Sponsor:   Assaf-Harofeh Medical Center Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 10, 2023 Category: Research Source Type: clinical trials